Medrad hopes to thrust new life into molecular imaging with its 510(k) pending FDG-PET power injector system called Intego, designed to promote greater accuracy in dose injection and which reportedly reduces radiation exposure related to FDG-handling by 40 percent.
April 8, 2008 - The first-in-man study funded by MIV Therapeutics Inc. (MIV) showed that MIV's VESTAsync stents ...
MEDRAD Inc. won a Medical Design Excellence Award (MDEA) for the MEDRAD XDS Extravasation Detector, a device for the ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
April 8, 2008 - Battelle, a nonprofit independent research and development organization, and MEDRAD Inc. won a Medical ...
April 8, 2008 - The government on Monday said it would raise payments next year to insurers that provide healthcare ...
April 8, 2008 - OrbusNeich received CE Mark approval for the Sapphire 1.25-mm PTCA dilatation catheter, a small-diameter ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
April 8, 2008 - A study using Itamar Medical's Endo-PAT2000, an FDA-cleared device used to assess endothelial function ...
Itamar Medical's Endo-PAT2000 is an FDA-cleared device used to assess endothelial function.
April 8, 2008 - Philips launched the latest addition to its HD ultrasound family of products, the Philips HD7, in the U ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
April 8, 2008 - Doctors at Boston Medical Center (BMC) led by Chief of Cardiac Surgery Robert Poston, M.D., have been ...
The Philips HD7 is a high-volume ultrasound system used in cardiovascular, OB/GYN, anesthesiology, oncology, electrophysiology, stress echo, pediatric, orthopedic, urologic, emergency and other applications.
April 8, 2008 - People who are taking three or more drugs and still have high blood pressure have a condition known as ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 8, 2008 - Atrial fibrillation demonstrated that a port access, paracardioscopic Ex-Maze procedure produced favorable outcomes and allowed patients to discontinue antiarrhythmic drugs, according to interim results from a study presented by Andy C. Kiser, M.D., at the American College of Cardiology meeting in Chicago, IL.
The Deficit Reduction Act of 2005 (DRA) has left its mark on hospitals and outpatient imaging center operators. There is no denying that the imaging industry has changed forever. Some may think that the 10 percent of operators on the brink of bankruptcy or in default on payments to finance vendors is a mere market correction for years of overgrowth. But do the math.
The Amsco V-PROTM 1 Low Temperature Sterilization System is designed to simplify clinicians' lives by improving ...
April 08, 2008
